Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-03

Clinical Trial Update: Micronized Purified Flavonoid- Fraction (MPFF) in the Management of Radiation Proctitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating micronized purified flavonoid fraction (MPFF) for management of radiation proctitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micronized Purified Flavonoid Fraction (MPFF) (micronized purified flavonoid fraction)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Proctitis Radiation | Phase 3 | Status: UNKNOWN